Introduction
============

Genome-editing by engineered sequence specific nucleases (SSNs) is a technological breakthrough that enables precise alterations to DNA, representing a new frontier in genetics. SSNs such as Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated systems (CRISPR/Cas9), Transcription activator like effector nucleases (TALENs), and more recently CRISPR/Cas12a (Cpf1, CRISPR from *Prevotella* and *Francisella* 1) generate double stranded breaks (DSBs) at pre-defined genomic loci. Furthermore, variants of SpCas9, SpCas9-HF1 (high-fidelity1) ([@B23]), eSpCas9 1.1 (enhanced specificity) ([@B19]), HypaCas9 (hyper-accurate Cas9) ([@B10]) and evoCas9 (evolved Cas9) ([@B7]) have been designed based on structure-guided protein engineering to reduce non-specific DNA interactions thereby minimizing genome-wide off-targets. The DSBs are repaired either by non-homologous end-joining (NHEJ), at times creating insertion/deletions that may knock out gene function, or by homology directed repair (HDR) using a repair donor template resulting in gene editing. Recently, genome-editing has been expanded to a number of plant species including model and crop species, and in some cases genome-editing has created agronomically valuable traits ([@B42]; [@B25], [@B24]; [@B18]; [@B40]; [@B47]; [@B48]; [@B13]; [@B29]; [@B46]; [@B5]; [@B8]; [@B11]; [@B26]; [@B43]; [@B55]).

Genome-editing reagents are delivered into plant cells via *Agrobacterium*-mediated transformation, protoplast transfection, or particle bombardment and typically, selection is employed to regenerate plants with integrated constructs, which intend to induce desired mutations ([@B52]). Plant transformation and regeneration processes from engineered cells and tissues typically require long and tedious tissue culture procedures. Thus, having access to a rapid method to test reagent activity prior to regeneration would be beneficial. Protoplasts isolated from plant tissue by enzymatic digestion of cell walls provide a platform to validate genome-editing reagents rapidly and each viable protoplast cell is totipotent, potentially capable of regenerating into a whole plant. Protoplasts have been used as a versatile tool for conducting cell based assays, analyzing diverse signaling pathways, studying functions of cellular machineries, and functional genomics screening ([@B41]; [@B53]; [@B33]; [@B49]; [@B51]). There are several advantages to a protoplast system for screening genome-editing reagents. First, isolation and transformation of protoplasts can be performed in less than a week. Second, protoplast transformation is a direct means to deliver genome-editing reagents and does not require a biological vector. Third, protoplasts can be used to generate thousands of independent events and aid in regenerating plants without incorporation of any foreign DNA ([@B18]; [@B13]). Fourth, protoplasts can be used to detect reporter genes by microscopy and are amenable to cell sorting ([@B51]).

Genome-editing using protoplast transformation and regeneration of whole plants with targeted modifications has been reported in various plant species ([@B24]; [@B40]; [@B47]; [@B44]; [@B48]; [@B13]; [@B29]; [@B22]; [@B26]). Recently, CRISPR/Cas12a and base editing systems along with DNA-free CRISPR delivery methods such as pre-assembled ribonucleoproteins (RNPs) have also been implemented in protoplasts to achieve targeted mutagenesis and whole plant regeneration ([@B48]; [@B22]; [@B55]; [@B2]).

Various approaches that aid in validation of genome-editing reagent constructs and detection of targeted mutagenesis in protoplasts prior to proceeding with time-consuming tissue culture transformation and regeneration procedures are available including the PCR/restriction enzyme digestion assay (PCR/RE) assay, the T7 endonuclease I (T7E1) assay and deep sequencing of targeted amplicons ([@B40]; [@B22]). For the PCR/RE assay, target amplicons are digested with restriction enzyme that can recognize wild type but not mutagenized sequence since the site is disrupted by SSNs. For the T7EI assay, the amplicons are denatured and re-annealed to form heteroduplexes that can be cleaved by T7EI. Deep sequencing of the target amplicons efficiently identifies targeted mutagenesis with high sensitivity. Besides these approaches, an alternative strategy for evaluation of *in vivo* activity of engineered genome-editing nucleases in protoplasts is described here. In this method that is adapted from the [G]{.ul}enome-wide [U]{.ul}nbiased [I]{.ul}dentification of [D]{.ul}ouble stranded breaks [E]{.ul}nabled by sequencing (GUIDE-seq) approach ([@B45]), on-target activity of reagents can be evaluated by integrating blunt double-stranded oligodeoxynucleotides (dsODNs) into the DSBs induced at target regions by a simple PCR reaction. CRISPR/Cas9, variants of Cas9, eCas9(1.1), Cas9-HF1 and TALEN reagents were engineered to target two loci, *Acetolactate synthase1* (*ALS1*) and *5-Enolpyruvylshikimate- 3-phosphate synthase* (*EPSPS1*) and their paralogs in potato. In summary, this method of dsODN integration and PCR detection can be used as a first evaluation step to rapidly screen multiple engineered SSNs in order to discard the non-functional reagents. All the tested methods are performed on common targets to further validate, compare, and quantify the targeted mutagenesis caused by SSNs and are widely applicable to any plant species in which protoplast isolation and transformation procedures are established.

Materials and Methods {#s1}
=====================

Vector Construction and Mutagenesis Using CRISPR/Cas9 and TALENs
----------------------------------------------------------------

*Acetolactate synthase1* and *EPSPS* genes were cloned and sequenced from the potato line DMRH-S5 28-5 ([@B34]). Single-guide RNA spacers targeting *ALS* ([@B6]) and *EPSPS* were designed in the coding sequence of target genes using CRISPR RGEN tools^[1](#fn01){ref-type="fn"}^. Equimolar amounts of sgRNA oligonucleotides are phosphorylated using polynucleotide kinase and T4 DNA ligase buffer and annealed together by boiling the reaction in a water bath for 3 min and letting it gradually cool down to room temperature. Double-strand sgRNAs were cloned into sgRNA expression vectors using modular assembly with the Golden Gate cloning system as described previously ([@B8]). Module A vector, pMOD_A0101 (Addgene \#90998) was used for AtCas9 expression cassette. eCas9(1.1) and Cas9-HF1 (pMOD_A6101 and pMOD_A6201, respectively) were made by amplification of the vector sequence from pMOD_A0101 for the backbone and most part of AtCas9 and sequence specific for Cas9 variants, was synthesized and fragments joined via Gibson assembly ([@B16]). Module B vector, pMOD_B2515 (Addgene \#91072) was used to clone sgRNAs downstream of AtU6 promoter. Module C vector, pMOD_C3006 (Addgene \#91094) was used for green fluorescent protein (GFP) expression that was driven by the FMV34S promoter. These A, B, and C modules were assembled into a transformation backbone vector pTRANS_100 (Addgene \#91198) for protoplast transformation. Target TALEN binding sites were designed using TAL Effector Nucleotide Targeter 2.0 and constructed according to [@B9], [@B8]) using Golden Gate cloning with NΔ152/C63 N- and C-terminal truncations, respectively, and P2A translational skipping sequence. Module A vector, pMOD_A1001 (Addgene \#90998) and Module B vector, pMOD_B2000 (Addgene \#91059) were used for TALEN constructs. All vector construction procedures were according to [@B8].

Plant Material and Growth Conditions
------------------------------------

All the experiments in this study were conducted using a diploid self-compatible potato line DMRH S5 28-5 developed by crossing *S. tuberosum* L. Group Phureja DM 1-3 516 R44 \[DM\] and *S. tuberosum* L. Group Tuberosum RH89-039-16 \[RH\] ([@B34]) and by selfing the fertile hybrid progeny for five generations. *In vitro* propagation and plant growth conditions are according to [@B32]. Briefly, plants are propagated using nodal cuttings on MS prop media (MS basal salts plus vitamins, 3% sucrose, 0.7% agar, pH 5.8) in tissue culture and grown in Magenta boxes in growth chambers with 16-h-light/8-h-night photoperiod at 22°C and average light intensity of 300 μmoles m^-2^ s^-1^.

Protoplast Isolation, Viability Evaluation, and Density Estimation
------------------------------------------------------------------

Protoplasts were isolated from immature leaves of 4-week-old *in vitro* propagated DMRH S5 28-5 leaves as described previously ([@B12]) with some modifications. Briefly, strips of leaves were excised directly into pre-plasmolysis medium ([Supplementary Table S1](#SM4){ref-type="supplementary-material"}) in the dark at room temperature for at least 4 h. Then, the leaf strips were digested in 1.25% (w/v) Cellulase R-10 'Onozuka,' 0.05% (w/v) Macerozyme R-10, half-strength MS salts and vitamins, 0.4 M mannitol and 0.1 M glucose and incubated at 28°C at 60 rpm in dark for 16--22 h. The digested product was filtered through a sterile 40 μm cell strainer, diluted with autoclaved rinse medium (0.3 M KCl + 5 mM CaCl~2~) and centrifuged at room temperature for 5 min at 50 ×*g*. The protoplast pellet was re-suspended in autoclaved flotation medium (0.5 M sucrose + 5 mM CaCl~2~) and layered on top of the protoplast suspension with 3 mL of rinse medium. After centrifugation at 50 ×*g* for 10 min, intact protoplasts were collected at the interface of these two solutions. Protoplasts are rinsed and re-suspended in culture medium ([Supplementary Table S1](#SM4){ref-type="supplementary-material"}) depending upon the size of the pellet. The density of living protoplasts was determined using a hemacytometer as described previously ([@B53]) and adjusted to the desired density (10^6^mL^-1^) with culture medium.

The viability of the protoplasts was evaluated by staining with 1% (w/v) Evans blue ([@B15]). The percentage of viable protoplasts was determined by dividing the number of unstained cells by the total cell count. Bright field images of the Evans blue stained protoplasts were acquired using Nikon C2 microscope with Nikon DS-U3 color camera having 20x UPlanSApo objective (NA 0.75). Nikon NIS Elements software version 5.00.00 was used to acquire and analyze images.

PEG-Mediated Transformation of Protoplasts
------------------------------------------

Protoplast transformation was performed based on the protocol described previously ([@B53]) with some modifications. The CRISPR/Cas9 and TALENs constructs were transformed into 100 μL of protoplast solution (containing 10^5^ protoplasts). To account for the differences in size of the plasmid constructs, varied amounts of each plasmid was used to ensure 2.57 pmol concentration in the transformations. 100 pM of annealed oligonucleotides ([@B45]) (2 μL of the prepared 50 pmol/μL) were mixed in with 2.57 pmol plasmid DNA per transformation reaction. Transformations with and without dsODNs in the reaction were carried out.

Protoplasts were gently mixed with 40 μL of plasmid DNA in the solution and 240 μL of filter sterilized 40% (w/v) polyethylene glycol transformation buffer (40% w/v PEG4000, 200 mM Mannitol, 100 mM CaCl~2~, pH 5.8) in round bottom 2 mL tubes. After 10 min incubation at room temperature, transformation was terminated by adding 900 μL of culture medium. Protoplasts were then collected by centrifuging for 5 min at 250 ×*g* at room temperature and washed one more time with 800 μL of culture medium by centrifuging for another 5 min at 250 ×*g*. Protoplasts were re-suspended in 200 μL of culture medium and placed in the dark at room temperature for 48 h before the genomic DNA isolation.

GFP Detection Using Confocal Laser Scanning Microscope
------------------------------------------------------

Green fluorescent protein signaling Images were taken 24 h after transformation. Olympus FluoView 1000 Confocal Laser Scanning Microscope (Olympus America, Inc., Center Valley, PA, United States) configured on a fully automated Olympus IX81 inverted microscope with a 10x UPlanSApo objective (NA 0.40) was used to collect the GFP fluorescence (green) from a single confocal plane as well as the corresponding transmitted laser light brightfield image (gray). GFP fluorescence was excited using the 488 nm Argon gas laser line and detected using a 505--525 nm band pass emission filter.

Protoplast Genomic DNA Isolation
--------------------------------

After 48 h post-transformation, genomic DNA was isolated from three biological replicates, each replication being a pool of six transformation reactions using the hexadecyltrimethylammonium bromide (CTAB)-based method ([@B36]). The genomic DNA was used as a template for dsODN insertion assay, T7EI, PCR/RE assays and amplicon sequencing library preparation.

T7EI and PCR/RE Assays
----------------------

The target regions of *ALS1* and *EPSPS1* were amplified using 10 ng of protoplast genomic DNA by Phusion High-Fidelity DNA Polymerase (Thermo Scientific). The PCR products were purified (Promega Wizard SV gel and PCR clean-up system) and quantified with using NanoDrop^TM^ 2000c spectrophotometer (Thermo Fisher, Wilmington, DE, United States). 1 μg of the purified PCR product was subjected to T7EI assay and PCR/RE assay.

The T7EI assay was performed as per the manufacturer's instructions (New England Biolabs). Briefly, the PCR products were denatured at 95°C, re-annealing was carried out by ramp PCR from 95 to 85°C at -2°C/s and 85 to 25°C at -0.1°C/s. These annealed PCR products were incubated with T7 endonuclease I (NEB) at 37°C for 1 h and analyzed via 2% (w/v) agarose gel electrophoresis. PCR bands were quantified using ImageJ software^[2](#fn02){ref-type="fn"}^ and the mutagenesis frequencies for SSNs were estimated using percent gene modification = 100 x (1 - (1--fraction cleaved)^1/2^) ([@B17]). The percentage of indels was calculated based on the relative intensity of the DNA bands using ImageJ software. The normalized indel percentage was calculated by dividing the indel percentage of the mutagenized samples with the WT.

For PCR/RE assay, PCR product of *ALS1* and *EPSPS1* are digested with *Bs*lI and *Xcm*I restriction enzymes respectively. Products were analyzed by agarose gel electrophoresis. The resistant band in both cases were cloned using Zero Blunt TOPO PCR cloning kit and Sanger sequenced to determine the mutant alleles present.

Double-Stranded Oligodeoxynucleotide (dsODN) Preparation
--------------------------------------------------------

Two modified oligonucleotides with 5^′^ phosphorylation (P)and 5^′^ and 3^′^ phosphorothioate linkages (^∗^) were synthesized byIDT^[3](#fn03){ref-type="fn"}^ (5^′^- P-G^∗^T^∗^TTAATTGAGTTGTCATATGTTAATAACGGT^∗^A^∗^T -3^′^ and 5^′^- P-A^∗^T^∗^ACCGTTATTAACATATGACAACTCAATTAA^∗^A^∗^C -3^′^). The blunt-ended dsODNs used in the study are prepared by annealing 100 μL of each oligonucleotide (100 μM) as described in vector construction to yield 50 pmol/μL dsODNs.

On-Target Detection of dsODN by PCR
-----------------------------------

To detect the insertion of dsODNs at the DSB in the target regions, four different PCR reactions were performed with a combination of one dsODN specific primer and one gene specific primer along with a control reaction using gene-specific primers. The primers used for all the assays and to detect dsODNs at the target site are listed in [Supplementary Table S2](#SM4){ref-type="supplementary-material"}.

AmpSeq: Illumina Library Preparation and Sequencing Analysis
------------------------------------------------------------

Genomic DNA extracted from transfected protoplasts for each of biological triplicates, and triplicated Indexed Illumina DNA sequencing libraries were constructed using a two-step PCR method. Primary PCR amplicons spanning the *ALS1* cleavage site, of which, the expected size was 365-bp without an indel, were amplified using the gene specific primers ([Supplementary Table S2](#SM4){ref-type="supplementary-material"}) with the following conditions: 98°C for 30 s; 14 cycles (98°C 10 s, 60°C 30 s, 72°C 30 s); 72°C for 5 min; hold at 12°C. The gene specific primers contained 5^′^ tails that were used to add the Illumina adaptor sequences onto the primary amplicons. Secondary PCR amplicons, of which, the expected size was 426-bp without an indel, were then amplified using primers that added 6-nt indexing barcodes and Illumina adaptor sequence to the secondary PCR amplicons (Conditions: 98°C for 30 s; 14 cycles (98°C 10 s, 50°C 30 s, 72°C 30 s); 72°C for 5 min; hold at 12°C). The secondary PCR amplicon samples were individually purified using AMPure XP beads according to manufacturer's instruction (Beckman Coulter, Brea, CA, United States); all purified samples were pooled with an equal molar ratio and run on a 1% agarose gel. The expected size bands were extracted and purified using The QIAquick Gel Extraction Kit (Qiagen, Valencia, CA, United States) according to the manufacturer's instruction. The libraries were then purified using AMPure XP beads according to manufacturer's instruction (Beckman Coulter, Brea, CA, United States) and the size distribution of amplicons was determined with the Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA, United States). The complete libraries were sequenced in 250 nt paired-end mode on the Illumina MiSeq using a MiSeq Reagent Nano kit ver2 (Illumina, San Diego, CA, United States) at the Research Technology Support Facility Genomics Core at Michigan State University. During the library construction, all PCR reactions were performed with Phusion High-Fidelity DNA Polymerase (New England BioLabs, Beverly, MA, United States). The list of primer sequences used in the library construction is provided in [Supplementary Table S2](#SM4){ref-type="supplementary-material"}.

For each library, read quality was accessed using the FastQC software (version 0.11.5)^[4](#fn04){ref-type="fn"}^. Reads were cleaned for quality and adapters were removed with Cutadapt software (version 1.8.1) ([@B30]) using minimum base quality of 20 retaining reads with a minimum length of 200 nucleotides after trimming. Cleaned reads were used for downstream analysis using CRISPResso ([@B35]). For CRISPResso analysis, the sgRNA sequence (5^′^-CTACCTATGATTCCCAG-3^′^) was provided and the window size of 15 bp around the cleavage site was used to quantify NHEJ events. To identify reads containing dsODN, the paired-end reads were merged using FLASH software (version 1.2.11) ([@B28]), and then converted to FASTA format using a custom script (5^′^-GTTTAATTGAGTTGTCATATGTTAATAACGGTAT-3^′^), the full sequence of dsODN, was searched against the merged reads using NCBI BLAST (version 2.6.0) ([@B1]). Any reads that contained the full or partial dsODN sequence were counted.

Statistical Analyses
--------------------

The statistical analyses for transformation efficiencies, NHEJ efficiencies, mutations types and mutagenesis were performed by Student's *t-*tests (two-tailed) or Duncan's Multiple Range tests using SAS (SAS Institute ^[5](#fn05){ref-type="fn"}^).

Results
=======

CRISPR/Cas9 and TALENs for Targeted Mutagenesis of *ALS* and *EPSPS* in Potato
------------------------------------------------------------------------------

The *ALS* and *EPSPS* genes are primary targets for different classes of herbicides, and specific mutations are known to confer resistance to the imidazolinone group of herbicides and glyphosate, respectively ([@B39]; [@B3]; [@B37]). Single guide RNAs (sgRNAs) and TALENs were designed for targeted mutagenesis of *ALS1* ([@B6]), *EPSPS1* ([Figure 1A,B](#F1){ref-type="fig"}) and their paralogs, *ALS2* and *EPSPS2* respectively, in potato ([Supplementary Table S3](#SM4){ref-type="supplementary-material"}). The expression cassettes of SSNs used for protoplast transient transformations co-expressing the GFP are shown in [Figure 1C](#F1){ref-type="fig"}. Two variants of AtCas9, Cas9-HF1 and eCas9 1.1, originally designed to reduce non-specific DNA interactions were also evaluated for mutagenesis of the same target genes. Details of all 16 plasmid constructs used in the study, target genes, and sequences are listed in [Supplementary Table S3](#SM4){ref-type="supplementary-material"}.

![Constructs for targeted mutagenesis of *ALS1* and *EPSPS1* loci in potato protoplasts using CRISPR/Cas9 and TALEN reagents. **(A)** Map of potato target gene *Acetolactate synthase1* (*ALS1*) and **(B)** *3-Phosphoshikimate 1-carboxyvinyltransferase* (*EPSPS1*) used in the study. The sequence of the target site is shown with sgRNA spacer in red, PAM in blue, TALEN binding sites are underlined, and restriction enzyme sites are in bold italicized. **(C)** Structure of the constructs used for expressing sgRNAs and TALENs co-expressing green fluorescent protein (GFP) for both target genes. PCaMV35S, cauliflower mosaic virus 35S promoter, AtCas9, Arabidopsis codon optimized Cas9 nuclease; tHSP, Arabidopsis heat shock protein 18.2 terminator; AtU6, Arabidopsis U6 promoter; sgRNA, single guide RNA*;* PFMV34S, figwort mosaic virus 34S promoter; GFP, green fluorescent protein; tE9, pea ribulose bisphosphate carboxylase small subunit terminator; P2A, ribosomal skipping sequence.](fpls-10-00110-g001){#F1}

Co-delivery of GFP With SSN Expression Cassettes to Compare Protoplast Transformation Efficiency Between CRISPR/Cas9 and TALENs Constructs
------------------------------------------------------------------------------------------------------------------------------------------

Viability of protoplasts isolated from leaves of *in vitro* propagated potato was determined using Evans blue staining, a non-permeating dye that is excluded by the cell plasma membrane, indicating cell viability. In contrast, a non-viable or damaged cell stains blue ([Figure 2a,b](#F2){ref-type="fig"}). On average, protoplast viabilities of 90 ± 4% (*n* = 12) were achieved ([Supplementary Figures S1A--F](#SM1){ref-type="supplementary-material"}). For detection of successful delivery and expression of the genome-editing reagents, GFP was co-delivered on the same plasmid as the Cas9 and TALEN expression cassettes ([Figure 1C](#F1){ref-type="fig"}). Using GFP fluorescence from the Cas9 and TALENs constructs targeting *ALS1*, protoplast transformation efficiency was optimized for cell density and time of exposure to polyethylene glycol (PEG). The transformation efficiency was highest at 100,000 protoplasts cell density per reaction and with a PEG exposure time of 5--10 min but was significantly reduced with PEG exposure times of 15--20 min (*P* ≤ 0.05) for Cas9 construct ([Supplementary Figures S1G,H](#SM1){ref-type="supplementary-material"}). However, for TALEN construct, efficiency remained constant at these conditions. Protoplast transformation efficiencies of up to 60-65% were achieved using Cas9 and TALEN-based constructs ([Figure 2c](#F2){ref-type="fig"}--[f](#F2){ref-type="fig"}).

![Determination of protoplast viability and transformation efficiency of genome-editing nucleases targeting *ALS1*. **(a)** Protoplasts isolated from *in vitro* grown potato leaves. **(b)** Protoplasts stained with Evans blue to test viability. Arrows indicate defective protoplast cells into which the dye permeated. Scale bar = 20 μ. **(c)** Transformation efficiencies are compared between the CRISPR/Cas9 and TALEN plasmid constructs targeting *ALS1*. Each bar represents the % mean value of three independent transformations, each with five technical replicates ± Standard deviation, Student's *t*-tests (*P* ≤ 0.05). **(d--f)** Confocal laser scanning microscope images showing, merged images of GFP fluorescence (green) and bright field (gray). CRISPR/Cas9 targeting *ALS1* **(d)**, TALENs targeting *ALS1* **(e)**, and no plasmid control **(f)** are shown. Scale bar = 100 μ.](fpls-10-00110-g002){#F2}

PCR/RE Assay Detects Targeted Mutagenesis of *ALS1* and *EPSPS1* by Disrupting the Restriction Site
---------------------------------------------------------------------------------------------------

PCR/RE assays were performed for *ALS1* and *EPSPS1* ([Figure 3A](#F3){ref-type="fig"}). Digestion of *ALS1* and *EPSPS1* amplicons from CRISPR/Cas9 constructs resulted in resistant bands indicating targeted mutagenesis. However, no digestion-resistant bands were obtained for TALENs as the TALEN cleavage sites did not disrupt the RE sites ([Figure 3B,C](#F3){ref-type="fig"}).

![Targeted mutagenesis of *ALS1* and *EPSPS1* detected by PCR/RE and T7EI assays. Three replications of CRISPR/Cas9 and TALENs are used in the assays. **(A)** Schematic of PCR/restriction enzyme digestion assay (PCR/RE) and resulting gel images of **(B)** *ALS1* and **(C)** *EPSPS1* in which the amplicons were digested with *BslI* and *XcmI*, respectively. Mutant bands resistant to digestion in **(B,C)** are indicated by red arrow and were cloned for Sanger sequencing. **(D)** Schematic of T7 Endonuclease I assay (T7EI) and resulting gel images of **(E)** *ALS1* and **(F)** *EPSPS1*. Arrows indicate expected cleavage products from targeted mutagenesis and indel percentage for each sample is indicated below. Sanger sequences of the targeted mutagenesis site of **(G)** *ALS1* and **(H)** *EPSPS1*. ^∗^ Denote the bands present in mutagenized samples only. Protospacer adjacent motif (PAM) is indicated in red. 100 bp NEB ladder; WT/D, wild type digested; WT/U, wild type un-digested.](fpls-10-00110-g003){#F3}

T7EI Assays Detect Targeted Mutagenesis of *ALS1* and *EPSPS1* by Cleavage of Heteroduplexes
--------------------------------------------------------------------------------------------

T7EI mismatch assays ([Figure 3D](#F3){ref-type="fig"}) for *ALS1* and *EPSPS1* from both Cas9 and TALENs constructs resulted in expected cleavage products indicative of induced insertion or deletion mutations (indels) at the target sites with mutagenesis percentages ranging from 40 to 47% for Cas9 and 10--32% for TALENs targeting *ALS1*, respectively ([Figure 3E](#F3){ref-type="fig"}). For the target gene *EPSPS1*, the bands corresponding to digestion-resistant amplicons ([Figure 3C](#F3){ref-type="fig"}) as well as T7EI assay ([Figure 3F](#F3){ref-type="fig"}) were less intense compared to *ALS1* indicating lower mutagenesis rates ranging from 11 to 26%.

Mutations were confirmed by cloning and sequencing the digestion-resistant bands ([Figure 3B,C](#F3){ref-type="fig"}), revealing deletions ranging from 1--10 bp in *ALS1* and 1--105 bp in *EPSPS1*, 5^′^ of the PAM sequence ([Figure 3G,H](#F3){ref-type="fig"}).

Quantification of Targeted Mutagenesis at *ALS1* Locus by Amplicon-Sequencing
-----------------------------------------------------------------------------

Deep sequencing of *ALS1* amplicons generated from CRISPR/Cas9 and TALENs reagents facilitated direct comparison of the efficiency of both reagents for the selected target and quantitatively determined the percentage of targeted mutagenesis along with types of mutations generated ([Figure 4](#F4){ref-type="fig"}). The overall frequency of targeted mutagenesis for *ALS1* was significantly higher with CRISPR/Cas9 (27.4%) compared to the TALENs (12.6%) (*P* ≤ 0.005) ([Figure 4A](#F4){ref-type="fig"}). Nucleotide deletions were the predominant type of mutations using both reagents with the frequencies of deletions and insertions using CRISPR/Cas9 (69, 23%) significantly higher than observed with TALENs (64, 16%), respectively ([Figure 4B](#F4){ref-type="fig"} and [Supplementary Figure S2](#SM2){ref-type="supplementary-material"}). The frequency of substitutions was significantly lower using CRISPR/Cas9 (8%) than with TALENs (20%) (*P* ≤ 0.005) ([Figure 4B](#F4){ref-type="fig"} and [Supplementary Figure S2](#SM2){ref-type="supplementary-material"}).

![Quantification of targeted mutagenesis at *ALS1* locus by amplicon sequencing. **(A)** Percentage of mutagenized reads at *ALS1* locus are shown using CRISPR/Cas9 and TALENs. The samples represent three biological replicates and three technical replicates of the PCR for each reagent, Student's *t-*test (*P* ≤ 0.005). **(B)** Frequency of the types of mutations in each sample are shown. Pie charts below represents the total average for each kind of mutation.](fpls-10-00110-g004){#F4}

Detecting CRISPR/Cas9 and TALEN Mediated On-Target Cleavage by Integration of a Blunt-Ended dsODN at the DSB Site in Protoplasts
--------------------------------------------------------------------------------------------------------------------------------

This method to evaluate on-target activity of SSNs ([Figure 5](#F5){ref-type="fig"}) relies on integration of blunt dsODNs into the DSBs and subsequent PCR amplification of dsODN-containing target sites. Protoplasts are transformed with plasmid constructs expressing engineered SSNs and dsODNs and genomic DNA is isolated from protoplasts 48 h after transformation ([Figure 5A](#F5){ref-type="fig"}). As SSNs generate DSBs at on- and off-target sites, integration of dsODNs creates a tag of known sequence at the target cleavage site. PCR using one dsODN-specific primer and one target gene specific primer results in detection of on-target cleavage activity of the SSN reagent at the target sites ([Figure 5B](#F5){ref-type="fig"}). dsODNs are modified oligonucleotides which are 5^′^ phosphorylated and end-protected with phosphorothioate linkages that protect them from rapid degradation ([@B45]) ([Figure 5C](#F5){ref-type="fig"}). These dsODNs are integrated into genomic DNA at the SSN induced DSBs in either forward 5^′^ or reverse 3^′^ orientation by means of NHEJ. Therefore, the directionality of integration is considered for PCR screening corresponding to four possibilities of on-target dsODN detection ([Figure 5D](#F5){ref-type="fig"}). Adapters are ligated and target is amplified for high throughput sequencing to detect mutagenesis quantitatively ([Figure 5E](#F5){ref-type="fig"}). On-target activity was detected with both CRISPR/Cas9 and TALEN reagents targeting *ALS1* and *EPSPS1* using dsODN integration method by PCR ([Figure 6A](#F6){ref-type="fig"}). The integration of the dsODN occurred using both reagents which generate variable DSBs in both 5^′^ and 3^′^ directions with no orientation bias ([Figure 6B,C](#F6){ref-type="fig"}). As expected, a control with only dsODNs without an SSN did not show any amplification with dsODN specific primers ([Figure 6B,C](#F6){ref-type="fig"}). The dsODN integration method was successfully validated in all 16 SSN constructs with AtCas9, Cas9-HF1, eCas91.1 and TALENs targeting regions of *ALS1*, *ALS2* ([Figure 7A,B](#F7){ref-type="fig"}), *EPSPS1* ([Supplementary Figures S3A,B](#SM1){ref-type="supplementary-material"}), and *EPSPS2* ([Supplementary Figures S4A,B](#SM1){ref-type="supplementary-material"}).

![Overview of dsODN integration method for evaluating targeted mutagenesis caused by SSNs in protoplasts. **(A)** Transient transformation of protoplasts with SSN plasmid constructs plus dsODNs (scale bar = 20 μ) and genomic DNA isolation. **(B)** Workflow for detecting SSN mediated on-target cleavage by insertion of a blunt ended dsODN at the double stranded break (DSB) site in protoplast cells and screening for qualitative assessment of functionality. **(C)** The dsODN with 5^′^ phosphorylation and end protection by phosphorothioate linkages at both 5^′^ and 3^′^ ends of both strands shown in red rectangle ([@B45]). **(D)** Schematic of dsODN insertion (red) in two possible directions at the target site, primers used for PCR screening along with a resulting gel image are shown. dsODN specific primers (2,3 in red are complementary to each other) and target gene specific primers (1,4 in blue) are used in combinations shown to consider directionality of dsODN integration. The expected results from the PCR reactions are presented. 1+4 reaction is a positive control. **(E)** Schematic of amplicon sequencing of dsODN inserted target sites. dsODN, double stranded oligodeoxynucleotide; SSN, sequence specific nuclease.](fpls-10-00110-g005){#F5}

![Detection of dsODNs integration in *ALS1* and *EPSPS1* by PCR. **(A)** dsODN insertion is shown at the DSB induced by SSN in target genes and arrows represent the primers used to detect the on-target activity of the dsODN ([Supplementary Table S2](#SM4){ref-type="supplementary-material"}). The order of PCR reactions for each SSN is shown **(B)** Gel image showing dsODN integration at *ALS1* and **(C)** *EPSPS1*. Target genes have been amplified using dsODN specific primer and gene specific primer. dsODN only is wild type/negative control without nuclease but with dsODNs to account for background DSBs. PCR amplicon sizes assuming one dsODN integration are given. DSB, double stranded break; M, NEB 100 bp ladder.](fpls-10-00110-g006){#F6}

![Detection of dsODNs integration by PCR using AtCas9, eCas9 (1.1) and Cas9-HF1 targeting *ALS1* and *ALS2*. Gel images showing dsODN integration at *ALS* locus at the DSB induced by variants of Cas9 including AtCas9, eCas9(1.1) and Cas9-HF1. **(A)** sg751 targets both *ALS1 and ALS2* and **(B)** sg746 is specific for *ALS1* ([Supplementary Table S3](#SM4){ref-type="supplementary-material"}). The order of PCR reactions for each SSN is according to [Figure 6A](#F6){ref-type="fig"}. dsODN only is wild type/negative control without nuclease but with dsODNs in the protoplast transformation reactions to account for background DSB. PCR amplicon sizes assuming one dsODN integration are given which are same for all Cas9 variants. eCas9(1.1), enhanced specificity Cas9; Cas9-HF1, high fidelity Cas9. M, 100 bp NEB ladder.](fpls-10-00110-g007){#F7}

dsODN Insertions at the *ALS1* Locus Suppressed Mutagenesis Frequencies
-----------------------------------------------------------------------

While PCR amplification of dsODN-target sites provided a qualitative assessment of on-target SSN activity ([Figure 6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"} and [Supplementary Figures S3](#SM1){ref-type="supplementary-material"}, [S4](#SM1){ref-type="supplementary-material"}), deep sequencing of *ALS1* amplicons from protoplast transformations with CRISPR/Cas9 and TALENs reagents in the presence of dsODNs not only quantitatively determined the percentage targeted mutagenesis but also dsODN integration frequencies using both reagents targeting *ALS1* ([Supplementary Table S4](#SM4){ref-type="supplementary-material"}). When dsODNs were included in the protoplast transfection reactions, integration of dsODNs was achieved at the target cleavage site approximately 3 bp upstream of the PAM sequence in case of CRISPR/Cas9 and in the middle of spacer sequence for TALEN reagents. dsODN molecules were integrated into the cleavage site without any directional bias with both reagents. Multiple sequence alignments of mutagenized sequences also show evidence of occasional tandem integrations of up to three dsODNs as well as partial integrations of dsODN at the target cleavage site ([Supplementary Figure S5](#SM3){ref-type="supplementary-material"}).

Surprisingly, the mutagenesis frequency was substantially suppressed to the extent of no SSN control when dsODNs were added in addition to the CRISPR/Cas9 or TALEN plasmid compared to reactions in which dsODNs were not included ([Supplementary Table S4](#SM4){ref-type="supplementary-material"}). Moreover, only 0.16 and 0.27% reads, respectively, contained dsODNs insertions in the cleavage site reflective of a small number of gene editing events ([Supplementary Table S4](#SM4){ref-type="supplementary-material"}). To further investigate if the presence of dsODNs suppressed protoplast transformation efficiency itself, protoplast transfections using CRISPR/Cas9 and TALENs targeting *ALS1* were carried out in the presence and absence of dsODNs and the efficiency of transformation was quantitatively determined by GFP signal (*n* = 3, 5 fields/rep) ([Supplementary Figures S6A--O](#SM1){ref-type="supplementary-material"}). No significant differences were observed in the transformation efficiencies (*P* ≤ 0.05) ([Supplementary Figures S6P,Q](#SM1){ref-type="supplementary-material"}) suggesting that dsODNs did not interfere in transformation but instead, inhibited mutagenesis.

Discussion
==========

Genome-editing represents a new frontier in crop improvement and is a rapidly evolving field with numerous advances increasing both accuracy and precision. While CRISPR/Cas9, TALENs, and other reagents have opened up greater possibilities of genetic manipulation and generation of genetic variability, the most commonly used methods for plant transformation, *Agrobacterium*-mediated transformation or biolistic delivery of transgenes, involve time-consuming tissue culture regeneration procedures. Thus, assessment of genome-editing activity can take several months depending on the species. Therefore, having a versatile cell-based evaluation system that enables large-scale screening of novel technical breakthroughs accelerates the process. Plant protoplasts, very similar to cell cultures in animal systems, serve as an indispensable tool for effective validation and rapid screening of *in vivo* activity of genome-editing SSNs ([@B27]; [@B8]). Protoplasts isolated from plant tissues retain their cell identity and differentiated state and are amenable to DNA transformation. Protoplast transformations can facilitate direct delivery of DNA to the cell and have short experimental duration with greater transformation efficiency compared to other methods ([@B20]; [@B14]; [@B4]). Multi-purpose toolkits developed for plant genome-editing have been validated in protoplasts owing to less time required and the possibility to examine millions of cells at a time. Robotic platforms recently developed for protoplast isolation and transformation further open the possibility of automated high throughput screening of SSNs ([@B50]; [@B27]; [@B38]; [@B8]). Co-expressing GFP along with SSN reagents in protoplasts not only ensured detection of the delivery and expression of genome-editing reagents in the cell but also facilitated direct comparison of the transformation efficiencies of CRISPR/Cas9 and TALEN reagents ([Figure 2](#F2){ref-type="fig"}). Protoplasts with GFP signal may also be enriched by fluorescence activated cell-sorting method (FACS) for downstream analyses such as sequencing.

T7EI and PCR/RE assays have been used for validation of genome-editing reagents and detection of mutagenesis ([Figure 3A,B](#F3){ref-type="fig"}). However, these methods have certain drawbacks for mutagenesis screening. For example, PCR/RE assay requires the presence of a restriction site in the target locus that will be disrupted by engineered SSNs. In addition to the absolute requirement of a PAM site in CRISPR systems, a restriction site adds yet another limitation to detect gene editing events and many times, it is difficult to find a suitable restriction site located at the cleavage site for the chosen target. Every target sequence requires a unique restriction enzyme thereby limiting the throughput of this assay. In addition, the restriction site position for the PCR/RE assay also depends upon the reagents used. For example, Cas9 generates a DSB approximately three bases upstream of the PAM sequence whereas TALENs cleave near the center of the spacer sequence. In this study, the PCR/RE assays resulted in yielding a positive signal from CRISPR constructs but not in the case of TALENs targeting *ALS1* and *EPSPS1* ([Figure 3C,D](#F3){ref-type="fig"}). The T7EI assay is another method to detect targeted mutagenesis independent of RE site. However, T7EI suffers from poor sensitivity, background signal and is not cost-effective for large scale screening and most often does not yield conclusive results when protoplast transformation efficiencies are poor ([Figure 3G,H](#F3){ref-type="fig"}). T7EI only cleaves heteroduplex DNA, formed as a result of annealing mutagenized DNA to wild type DNA without mutations. Thus, mutant homoduplexes along with wild type alleles remain intact. In addition, the structure of heteroduplex formed is affected by the target sequence and number of nucleotides that mismatch between the two strands of DNA, ultimately affecting the cleavage efficiency by T7EI ([@B31]). T7EI assay is also sensitive to DNA/enzyme ratios and incubation time and is particularly susceptible to false-positive signal from amplification of non-identical paralogs. Deep sequencing of the amplicons represents a highly sensitive method for determining targeted mutagenesis frequencies, however requires high throughput sequencing, additional bio-informatic skills to analyze the data and is not cost effective for using it as an initial screening strategy. Furthermore, large insertions or deletions spanning primer binding sites cannot be detected by this method.

Evaluation of on-target activity of SSNs based on the capture of dsODNs into nuclease-induced DSBs in living cells is an alternative method. Unlike the other existing methods, there is no pre-requisite condition required for this method and it is independent of the type of DSB or context of the cleavage site and works robustly with broad range of reagents (with a blunt/staggered cleavage) using a simple PCR reaction. The workflow of the procedure ([Figure 5](#F5){ref-type="fig"}) is adapted from GUIDE-seq approach, developed in human cells to identify genome-wide off-targets caused by CRISPR/Cas nucleases without having to sequence the whole genome ([@B45]). This procedure enables enrichment of those sites with dsODN insertion and sequencing only the adjacent genomic regions, thereby facilitating identification of genome-wide cleavage sites. Here, the GUIDE-seq method has been adapted also for TALENs in addition to CRISPR/Cas9 for the first time in plant protoplasts as a screening methodology to evaluate success of the designed construct for targeted mutagenesis providing a method to identify reagents that lack gene editing activity. By including end-protected 34 nt dsODNs along with the plasmid SSN expression constructs in the protoplast transformation reaction, we are able to evaluate the on-target activity of the SSN. The end modifications on dsODNs protect them from nuclease degradation in the cell, allowing for integration into the genomic DNA at the cleavage site ([@B45]). Integration of dsODN occurred in both Cas9-mediated blunt ended DSBs as well as TALEN-mediated staggered DSBs ([Figure 6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"} and [Supplementary Figures S3](#SM1){ref-type="supplementary-material"}, [S4](#SM1){ref-type="supplementary-material"}). Similarly, integration of dsODN in Cas12a (Cpf1)-induced staggered cuts has been previously reported in human cells ([@B21]) thereby making this method applicable to current genome-editing platforms being used. While detection of dsODN integration at a target site by PCR without any high-throughput sequencing provides a rapid qualitative assessment of reagents, it is not a quantitative measure of gene editing and is unable to distinguish mono-allelic from bi-allelic events. The rates of integration of dsODNs were reported to be only two- to threefold lower than the frequencies of indels in human cell gene editing events ([@B45]). Yet in plant protoplasts cells, dsODN integration rates were much lower suggesting that the signal we detect for on-target activity evaluation using this method is much lower than the actual mutagenesis itself.

Amplicon sequencing of protoplast DNA treated with dsODNs and nucleases further revealed that mutagenesis rates at the genomic target were drastically reduced ([Supplementary Table S4](#SM4){ref-type="supplementary-material"}). We hypothesized that the high concentration of dsODN molecules cause cellular toxicity resulting in cell death, thereby excluding dsODN-containing cells within the population from mutagenesis. However, GFP-based quantification of transformation efficiency, an indirect assessment of cell viability, with or without dsODN treatment showed no significant differences in fluorescence detection after 24 h, suggesting that the presence of dsODNs is not cytotoxic ([Supplementary Figure S6](#SM1){ref-type="supplementary-material"}). An alternative explanation for this reduced mutagenesis frequency is that the presence of a large number of small DNA molecules (dsODNs) interferes with the ability of both Cas9 and TALENs to locate and/or cleave the genomic target, resulting in fewer DSBs. Alternatively, the presence of a large number of small DNA molecules saturates the native exonucleases in the treated cells, resulting in less exonuclease activity on the genomic target. Without exonucleases acting on the genomic DSB, the NHEJ/HR repair machinery repairs the DSB without the formation of indels. We would suggest that the latter explanation is more likely based on the fact that large amounts of DNA amplicons does not affect Cas9 activity ([@B54]). Additionally, it has been shown that over-expression of the 3^′^ exonuclease TREX2 increases mutation frequency ([@B8]), suggesting that decreased exonuclease activity (due to native exonucleases attempting to degrade the dsODNs) would result in fewer mutations at genomic DSBs.

For PCR detection, relatively few events are required to amplify the ODN integration at the target site and we were able to detect the signal on a gel every time we have used this method. We routinely use the dsODN method in our lab to evaluate the functionality of gene-editing constructs prepared within a 1-week time period by readily detecting on-target activity of reagents ([Figure 6](#F6){ref-type="fig"}, [7](#F7){ref-type="fig"} and [Supplementary Figures S3](#SM1){ref-type="supplementary-material"}, [S4](#SM1){ref-type="supplementary-material"}), well before proceeding with time-consuming *Agrobacterium*-mediated stable transformation. Annealed dsODNs and primers specific to dsODNs are common to any screen, thereby the only variable being gene specific primers for testing multiple targets. This method, as demonstrated by GUIDE-seq in human cells, may not be optimal for detecting genome-wide off-targets in plant cells without further optimization due to low integration frequencies of dsODNs and suppression of mutagenesis ([Supplementary Table S4](#SM4){ref-type="supplementary-material"}). However, this method can be used to detect dsODN integration in the *in silico* predicted off-targets. Potential parameters for optimization in protoplasts include, titrating down the dsODN concentrations to empirically find the right amounts of plasmid and dsODNs for each transformation reaction or use dsODNs with decreased phosphorothioate linkage protection, for e.g., only on 3^′^ end of the molecule. As the GUIDE-seq method does not involve whole genome sequencing, when optimized for dsODN integration, it can be broadly used to survey various genome-editing reagents for genome-wide off-targets in various crop species. GUIDE-seq could also identify genomic breakpoint 'hotspots' independent of SSNs, thereby has the potential to study meiotic recombination hotspots and chromosomal translocations resulting from joining of on- and off-targets can also be detected using this method ([@B45]).

This study compares the existing methods for assessment of *in vivo* activity of engineered genome editing nucleases and also introduces a new strategy adapted from human cells, adding yet another tool to screen for targeted mutagenesis in plant protoplast cells. By high-throughput sequencing, the mutagenesis frequencies as well as types of mutations caused by both CRISPR/Cas9 and TALENs reagents targeting the same gene of interest are compared. Furthermore, our results based on assessment of various screening methodologies indicate that the choice of method is context dependent and initial screening can be achieved in a cost-effective manner in protoplast system. The pros and cons for each strategy are discussed providing guidelines for selection of method for evaluation of targeted mutagenesis.
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